Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 1/20 | 0.53 |
| ▸ | ACE | P12821 | 1/20 | 0.51 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.50 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | REN | P00797 | 6/20 | 0.46 |
| ▸ | CTSD | P07339 | 3/20 | 0.46 |
| ▸ | BACE1 | P56817 | 3/20 | 0.46 |
| ▸ | CTSS | P25774 | 2/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.44 |
| ▸ | CAPN2 | P17655 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27895748 | 0.85 | TACR1 (0.53) | MMP9SLC15A1ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL24633781 | 0.84 | ALDH1A1 (0.53) | MMP9SLC15A1ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL6675104 | 0.84 | CTSK (0.54) | MMP9SLC15A1CTSKCTSSCTSL | |
| SCHEMBL755795 | 0.83 | MMP9 (0.52) | MMP9SLC15A1CTSKALDH1A1MAPK1 | |
| SCHEMBL2912589 | 0.83 | CASP1 (0.60) | CTSKALDH1A1CTSSCTSLCTSB | |
| SCHEMBL7583002 | 0.83 | CASP1 (0.60) | CTSKALDH1A1CTSSCTSLCTSB | |
| SCHEMBL2912586 | 0.83 | CASP1 (0.60) | CTSKALDH1A1CTSSCTSLCTSB | |
| SCHEMBL111390 | 0.82 | ALDH1A1 (0.61) | MMP9SLC15A1CTSKALDH1A1MAPK1 | |
| SCHEMBL28269654 | 0.82 | FAAH (0.56) | PSMB5ALDH1A1 | |
| SCHEMBL25454647 | 0.82 | SLC15A1 (0.53) | MMP9SLC15A1CTSKALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170143835-A1 | SUBSTITUTED ANIONIC COMPOUNDS CONSISTING OF A BACKBONE MADE UP OF A DISCRETE NUMBER OF SACCHARIDE UNITS | ADOCIA (FR) | 2017-05-25 | — | — | US | disclosed |
| US-20170143835-A1 | SUBSTITUTED ANIONIC COMPOUNDS CONSISTING OF A BACKBONE MADE UP OF A DISCRETE NUMBER OF SACCHARIDE UNITS | ADOCIA (FR) | 2017-05-25 | — | — | US | disclosed |
| US-20140187499-A1 | SUBSTITUTED ANIONIC COMPOUNDS CONSISTING OF A BACKBONE MADE UP OF A DISCRETE NUMBER OF SACCHARIDE UNITS | ADOCIA (FR) | 2014-07-03 | — | — | US | disclosed |
| US-20140187499-A1 | SUBSTITUTED ANIONIC COMPOUNDS CONSISTING OF A BACKBONE MADE UP OF A DISCRETE NUMBER OF SACCHARIDE UNITS | ADOCIA (FR) | 2014-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170143835-A1 | SUBSTITUTED ANIONIC COMPOUNDS CONSISTING OF A BACKBONE MADE UP OF A DISCRETE NUMBER OF SACCHARIDE UNITS | ALG8, FUT8, UGT8 | MMP9 3442/4885ACE 540/4885SLC15A1 552/4885 |
| US-20140187499-A1 | SUBSTITUTED ANIONIC COMPOUNDS CONSISTING OF A BACKBONE MADE UP OF A DISCRETE NUMBER OF SACCHARIDE UNITS | FUT6, FUT5, FUT8 | MMP9 2880/4885ACE 609/4885SLC15A1 1159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.